abstract |
The invention relates to novel tri-substituted pyrimidines of formula (I), where Ra to Re are as defined in claim 1, which are suitable for treatment of diseases in which β-amyloid modulators have a therapeutic effect, the use thereof for the production of a medicament with the above properties and method for production thereof. |